GLP-1 receptor agonist 2 is primarily used in the treatment of type 2 diabetes due to its ability to enhance insulin secretion in response to meals. It works by mimicking the action of the naturally occurring hormone GLP-1, which helps regulate blood sugar levels. Additionally, this compound slows gastric emptying, leading to a reduced appetite and aiding in weight management, which is beneficial for diabetic patients who often struggle with obesity. Beyond diabetes, it is also being explored for its potential in treating obesity and related metabolic disorders, offering a dual benefit of glycemic control and weight reduction. Its use is typically administered via injection, ensuring consistent therapeutic effects.